Spatially confined sub-tumor microenvironments in pancreatic cancer - ScienceDirect
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma | PLOS ONE
Cancer prevention and screening: the next step in the era of precision medicine | npj Precision Oncology
Emerging molecular markers of cancer | Nature Reviews Cancer
Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma | PLOS ONE
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers | Science Translational Medicine
Hypermutation In Pancreatic Cancer - Gastroenterology
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 4 (2021)
PDF) Study of Microsatellites Role in BRCA2 Gene Causing Pancreatic Cancer and Breast Cancer | P. Anuradha and Prof. Ravi Shankar Nowpada - Academia.edu
PDF) Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study - Annals of Oncology
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 4 (2021)
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 4 (2021)
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma
Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer
Frontiers | Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer
Diagnostics | Free Full-Text | The Utility of Endoscopic-Ultrasonography-Guided Tissue Acquisition for Solid Pancreatic Lesions | HTML
Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer
Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma - ScienceDirect
Current Treatment Landscape and Emerging Therapies for Pancreatic Cancer
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma | Nature Genetics
Cancers | Free Full-Text | Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer | HTML
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer | Scientific Reports
